Janssen&Janssen schreef op 9 april 2022 11:45:
Wel leuk om te lezen hoe partijdig je bent wat betreft Pharming en zij. Concolllegas. Elke dag/week zagen& hameren dat Ruconest met hun injectie de langste tijd heeft gehad omdat concollegas betere toediening methodes hebben . Maar vervolgens bovenstaande post plaatsen alsof de concollega het wonderwiel heeft uit gevonden. Maar er wel niet bij noem hoe deze wordt toegediend.
At ATU entry, all patients were prescribed subcutaneous lanadelumab 300 mg every 2 weeks. Dosage adjustments could be made at physician discretion after =?6 months of treatment. Pharmacists dispensed lanadelumab on a monthly basis, as prescribed by the physicians.
Injection training and injection use satisfaction
At the time of data cut-off, 62 patients had completed a patient diary regarding the ease with which they learned how to inject lanadelumab at D0. The majority of patients (77%) had received a practical demonstration by a nurse or physician, 27% were informed via leaflets, and 10% reported “other” methods (one patient received a verbal explanation by a nurse and four patients already knew how to use an injection).
Most patients (71%, based on n?=?54) found their method of learning to be very easy (mean [SD] score 8.8 [2.0]), based on a scale of 1 (very difficult) to 10 (very easy). Overall satisfaction levels regarding ease of lanadelumab administration remained generally consistent throughout the follow-up period. Based on a scale of 1 (not at all satisfied) to 10 (very satisfied), the mean (SD) overall satisfaction level was 8.1 (1.9) at month 1 (injection 1; n?=?59) and 8.7 (1.7) at month 6 (injection 2; n?=?26).aacijournal.biomedcentral.com/article...